Cargando…

The role of complement in the clinical course of hepatocellular carcinoma

BACKGROUND: The complement system, an innate immune system, may either play an antitumor role, or promote tumorigenesis and cancer progression in different kinds of cancer. The function of complement in hepatocellular carcinoma (HCC) is unclear. METHODS: The gene expressions of the complement system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Xinye, Yang, Zhoujing, Gao, Lu, Liu, Yipiao, Yan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926509/ https://www.ncbi.nlm.nih.gov/pubmed/34813686 http://dx.doi.org/10.1002/iid3.569

Ejemplares similares

The long non‐coding RNA HLNC1 potentiates hepatocellular carcinoma progression via interaction with USP49
por: Qian, Xinye, et al.
Publicado: (2020)

An update on the role of complement in hepatocellular carcinoma
por: Xiao, Zhijie, et al.
Publicado: (2022)

Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma: Complement-associated molecular features in hepatocellular carcinoma
por: Huang, Run, et al.
Publicado: (2022)

MM-associated circular RNA downregulates microRNA-19a through methylation to suppress proliferation of pancreatic adenocarcinoma cells
por: Qian, Xinye, et al.
Publicado: (2022)

Mechanical Bowel Preparation Is a Risk Factor for Postoperative Delirium as It Alters the Gut Microbiota Composition: A Prospective Randomized Single-Center Study
por: Yang, Zhoujing, et al.
Publicado: (2022)

Clinical course and role of embolization in patients with spontaneous rupture of hepatocellular carcinoma
por: Park, Juil, et al.
Publicado: (2022)

Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma
por: Qian, Xinye, et al.
Publicado: (2022)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
por: An, Jihyun, et al.
Publicado: (2022)

Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
por: Ning, Gang, et al.
Publicado: (2020)

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma
por: Wei, Xiaolin, et al.
Publicado: (2023)

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
por: Feng, Honglei, et al.
Publicado: (2021)

The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis
por: Cheng, Zhoujing, et al.
Publicado: (2020)

Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma
por: Liao, Jian-Hua, et al.
Publicado: (2017)

“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
por: Malik, Astha, et al.
Publicado: (2021)

Roles and regulation of histone acetylation in hepatocellular carcinoma
por: Xia, Jin-kun, et al.
Publicado: (2022)

Identification of the Sixth Complement Component as Potential Key Genes in Hepatocellular Carcinoma via Bioinformatics Analysis
por: Mu, Di, et al.
Publicado: (2020)

Role of CD5 molecular-like on hepatocellular carcinoma
por: Gao, Zhaowei, et al.
Publicado: (2023)

Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma
por: Yang, Cheng-Lei, et al.
Publicado: (2021)

Study on the mechanism of aging-related erectile dysfunction based on bioinformatics and experimental verification
por: Sun, Taotao, et al.
Publicado: (2023)

The down-regulation of GNAO1 and its promoting role in hepatocellular carcinoma
por: Pei, Xiaoyu, et al.
Publicado: (2013)

Complement factor H-related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis
por: Liu, Hong, et al.
Publicado: (2019)

A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients
por: Man, Zhongsong, et al.
Publicado: (2021)

MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/β-catenin signaling
por: Bai, Jinping, et al.
Publicado: (2019)

Role of Surface Charge of Nanoscale Ultrasound Contrast Agents in Complement Activation and Phagocytosis
por: Zhou, Jie, et al.
Publicado: (2022)

The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
por: Huang, Yu, et al.
Publicado: (2021)

The course and prognostic value of tumor stiffness detected by ultrasound elastography for transarterial chemoembolization of hepatocellular carcinoma
por: Hou, Suyun, et al.
Publicado: (2023)

A Case of Humoral Hypercalcemia of Malignancy Secondary to Hepatocellular Carcinoma with Fulminant Clinical Course
por: Castro-Camero, Pamela, et al.
Publicado: (2019)

Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma
por: Yang, Lu, et al.
Publicado: (2018)

Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes
por: de Nooijer, Aline H, et al.
Publicado: (2020)

Expression and clinical significance of Nectin-4 in hepatocellular carcinoma
por: Ma, Jie, et al.
Publicado: (2016)

C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients
por: Zhang, Yuan, et al.
Publicado: (2021)

Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3
por: Xu, Yaping, et al.
Publicado: (2020)

Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection
por: Ni, Xiao-Chun, et al.
Publicado: (2020)

The role of RNA modification in hepatocellular carcinoma
por: Feng, Qiang, et al.
Publicado: (2022)

Role of superoxide dismutase in hepatitis B virus-related hepatocellular carcinoma
por: Zhang, Xiaolian, et al.
Publicado: (2016)

Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2(+) γδ T cell can be a promising complement
por: He, Wenjing, et al.
Publicado: (2022)

PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma
por: Zhang, Lili, et al.
Publicado: (2023)

Distribution and clinical relevance of phospholipids in hepatocellular carcinoma
por: Liu, Zhirong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2ukaqa2rbommfndiki1j1a2fs